Please be advised that the above mention product will have a MAJOR price DECREASE in the Pharmaceutical Schedule effective 1 July 2019.

This is as a result of the Invitation to Tender 2018/2019.

Current price is $600.00

New price will be $60.00

As of the date of this notification ProPharma / PWR cannot accept Aclasta Inj for credit under any circumstances.

This caution gives pharmacy sufficient time to manage their stock and ensure they do not get caught with high value stock come 1 July 2019.

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author